CClinicalTrials.gg
CompletedNCT02966015Updated Feb 28, 2018Results posted

Product Evaluation of a Newly Developed Intermittent Catheter.

An interventional study of Coloplast test catheter in Incontinence, Urinary, sponsored by Coloplast A/S. Completed. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-02-28.

Sponsored by Coloplast A/S · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
153
Allocation
Not applicable
Ages
18 Years and older
Sex
Male
01

Study summary

The aim of the study is to investigate the navigation of a newly developed catheter.

02

Conditions studied

  • Incontinence, Urinary
03

In context

Urinary Incontinence

1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.

This study's enrollment of 153 is above the median of 66 across 1,011 interventional studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

Coloplast A/S is the lead sponsor of 146 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  1. Male and at least 18 years
  2. Has used Intermittent self-catheterization at least 3 months
  3. Has normal to slightly reduced hand mobility
  4. Use catheter size CH12 or CH14 (must use same size during product evaluation)

Exclusion criteria

Exclusion Criteria:

  1. Currently receiving treatment for urinary tract infection
  2. Currently receiving chemotherapy
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
153 participants (actual)

Study arms

  • Experimental
    Testing the new Coloplast Test catheter

    The subjects used the new Coloplast Test catheter for 1 week

    Device: Coloplast test catheter

Interventions

  • DeviceColoplast test catheter

    This is a newly developed catheter

06

What researchers measure

Primary outcomes

  1. Number of Participants Successfully Able to Insert Catheter

    The subjects had to evaluate if it was possible to insert and navigate the Coloplast Test catheter through urethra by the 5-point Likert question: "How did you find the catheter navigates through the urethra during insertion" ( Very easily, Easily, Neither/nor, Difficultly, Very difficultly, Not possible). The catheterization was considered successful if it was possible to insert the catheter, meaning that ifthey selected any other answer than 'not possible'.

    Time frame: 1 week

07

Results

Posted Dec 8, 2017

Participant flow

Inclusion Visit
Participant flow — Inclusion Visit
MilestoneTiemann/Coudé UsersTraditional Sleeve Catheter Users
Started9558
Completed8755
Not completed83
Withdrew: Did not answer questionnaire83
Test Period
Participant flow — Test Period
MilestoneTiemann/Coudé UsersTraditional Sleeve Catheter Users
Started8755
Completed8755
Not completed00

Outcome measures

PrimaryNumber of Participants Successfully Able to Insert Catheter

The subjects had to evaluate if it was possible to insert and navigate the Coloplast Test catheter through urethra by the 5-point Likert question: "How did you find the catheter navigates through the urethra during insertion" ( Very easily, Easily, Neither/nor, Difficultly, Very difficultly, Not possible). The catheterization was considered successful if it was possible to insert the catheter, meaning that ifthey selected any other answer than 'not possible'.

Time frame:
1 week
Reported as:
Count of participants · Participants
Number of Participants Successfully Able to Insert Catheter
ParticipantsTiemann/Coudé UsersTraditional Sleeve Catheter Users
Number of Participants Successfully Able to Insert Catheter8258

Adverse events

Collected over Adverse events were collected during the trial period. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Tiemann/Coudé Users0/95 (0%)0/95 (0%)0/95 (0%)
Traditional Sleeve Catheter Users0/58 (0%)0/58 (0%)0/58 (0%)

Baseline characteristics

All the subjects enrolled in the study

Age, Customized
Age, Customized(participants)Tiemann/Coudé UsersTraditional Sleeve Catheter UsersTotal
Participants older than 18 years9558153
Sex: Female, Male
Sex: Female, Male(Participants)Tiemann/Coudé UsersTraditional Sleeve Catheter UsersTotal
Female000
Male9558153
08

Study locations

No study locations are listed for this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02966015
Lead sponsor
Coloplast A/S
Responsible party
Sponsor
First posted
Nov 17, 2016
Start date
May 2016
Primary completion
May 2016
Completion
Jun 2016
Results posted
Dec 8, 2017
Last update
Feb 28, 2018

Study contacts

Camilla F Vibjerg, Msc
study chair · Head of clinical operation

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion